Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

Fig. 5

a Forest plots of the pooled RR for the sub-analysis of node status effect in DFS between sequential and concurrent regimens. The results indicated that there was a significantly better DFS in patients with node-positive status who were administrated a sequential regimen (RR, 1.08; 95% CI, 1.02-1.14, P = 0.004). b Forest plots of the pooled RR for the sub-analysis of node status effect in DFS between sequential and concurrent regimens. The results indicated that there was no significant difference in OS in patients with node-positive/negative status between concurrent and sequential regimens (RR, 1.07; 95% CI, 0.96-1.19, P = 0.24)

Back to article page